| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
|
Pitts, Elizabeth G.
|
|
|
17 |
Suppl 1 |
p. 165-177
|
article
|
| 2 |
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
|
Pitts, Elizabeth G.
|
|
|
17 |
Suppl 1 |
p. 165-177
|
article
|
| 3 |
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
|
Pitts, Elizabeth G.
|
|
|
17 |
Suppl 1 |
p. 165-177
|
article
|
| 4 |
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
|
Xu, Weilin
|
|
|
17 |
Suppl 1 |
p. 294-308
|
article
|
| 5 |
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
|
Xu, Weilin
|
|
|
17 |
Suppl 1 |
p. 294-308
|
article
|
| 6 |
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
|
Xu, Weilin
|
|
|
17 |
Suppl 1 |
p. 294-308
|
article
|
| 7 |
Adhering to Ethical Benchmarks in Neurology Clinical Trials Using iPSCs
|
Akabayashi, Akira
|
|
|
17 |
Suppl 1 |
p. 606-608
|
article
|
| 8 |
Adhering to Ethical Benchmarks in Neurology Clinical Trials Using iPSCs
|
Akabayashi, Akira
|
|
|
17 |
Suppl 1 |
p. 606-608
|
article
|
| 9 |
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
|
Nakagaki, Takehiro
|
|
|
17 |
Suppl 1 |
p. 1850-1860
|
article
|
| 10 |
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
|
Nakagaki, Takehiro
|
|
|
17 |
Suppl 1 |
p. 1850-1860
|
article
|
| 11 |
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
|
Oberlin, Brandon G.
|
|
|
17 |
Suppl 1 |
p. 70-86
|
article
|
| 12 |
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
|
Oberlin, Brandon G.
|
|
|
17 |
Suppl 1 |
p. 70-86
|
article
|
| 13 |
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
|
Oberlin, Brandon G.
|
|
|
17 |
Suppl 1 |
p. 70-86
|
article
|
| 14 |
Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies
|
Sang, Christine N.
|
|
|
17 |
Suppl 1 |
p. 765-769
|
article
|
| 15 |
Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies
|
Sang, Christine N.
|
|
|
17 |
Suppl 1 |
p. 765-769
|
article
|
| 16 |
Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer’s Disease
|
Chen, Shuhua
|
|
|
17 |
Suppl 1 |
p. 1813-1824
|
article
|
| 17 |
Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease
|
Chen, Shuhua
|
|
|
17 |
Suppl 1 |
p. 1813-1824
|
article
|
| 18 |
Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model
|
Wang, Tian
|
|
|
17 |
Suppl 1 |
p. 178-188
|
article
|
| 19 |
Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model
|
Wang, Tian
|
|
|
17 |
Suppl 1 |
p. 178-188
|
article
|
| 20 |
Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model
|
Wang, Tian
|
|
|
17 |
Suppl 1 |
p. 178-188
|
article
|
| 21 |
Anterior Cingulate Cortex Implants for Alcohol Addiction: A Feasibility Study
|
Leong, Sook Ling
|
|
|
17 |
Suppl 1 |
p. 1287-1299
|
article
|
| 22 |
Anterior Cingulate Cortex Implants for Alcohol Addiction: A Feasibility Study
|
Leong, Sook Ling
|
|
|
17 |
Suppl 1 |
p. 1287-1299
|
article
|
| 23 |
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
|
Dimitriadou, Maria M.
|
|
|
17 |
Suppl 1 |
p. 235-242
|
article
|
| 24 |
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
|
Dimitriadou, Maria M.
|
|
|
17 |
Suppl 1 |
p. 235-242
|
article
|
| 25 |
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
|
Dimitriadou, Maria M.
|
|
|
17 |
Suppl 1 |
p. 235-242
|
article
|
| 26 |
Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned
|
Hung, Albert Y.
|
|
|
17 |
Suppl 1 |
p. 1393-1405
|
article
|
| 27 |
Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned
|
Hung, Albert Y.
|
|
|
17 |
Suppl 1 |
p. 1393-1405
|
article
|
| 28 |
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease
|
Fischer, D. Luke
|
|
|
17 |
Suppl 1 |
p. 1785-1795
|
article
|
| 29 |
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease
|
Fischer, D. Luke
|
|
|
17 |
Suppl 1 |
p. 1785-1795
|
article
|
| 30 |
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use
|
Tseng, Li-Yen
|
|
|
17 |
Suppl 1 |
p. 156-164
|
article
|
| 31 |
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use
|
Tseng, Li-Yen
|
|
|
17 |
Suppl 1 |
p. 156-164
|
article
|
| 32 |
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use
|
Tseng, Li-Yen
|
|
|
17 |
Suppl 1 |
p. 156-164
|
article
|
| 33 |
CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice
|
Yan, Jun
|
|
|
17 |
Suppl 1 |
p. 1170-1183
|
article
|
| 34 |
CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice
|
Yan, Jun
|
|
|
17 |
Suppl 1 |
p. 1170-1183
|
article
|
| 35 |
Cell Death and Recovery in Traumatic Brain Injury
|
Akamatsu, Yosuke
|
|
|
17 |
Suppl 1 |
p. 446-456
|
article
|
| 36 |
Cell Death and Recovery in Traumatic Brain Injury
|
Akamatsu, Yosuke
|
|
|
17 |
Suppl 1 |
p. 446-456
|
article
|
| 37 |
Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain
|
Donnelly, Christopher R.
|
|
|
17 |
Suppl 1 |
p. 846-860
|
article
|
| 38 |
Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain
|
Donnelly, Christopher R.
|
|
|
17 |
Suppl 1 |
p. 846-860
|
article
|
| 39 |
Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate
|
Carlström, Karl E.
|
|
|
17 |
Suppl 1 |
p. 1142-1152
|
article
|
| 40 |
Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate
|
Carlström, Karl E.
|
|
|
17 |
Suppl 1 |
p. 1142-1152
|
article
|
| 41 |
Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats
|
Qian, Junliang
|
|
|
17 |
Suppl 1 |
p. 722-742
|
article
|
| 42 |
Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats
|
Qian, Junliang
|
|
|
17 |
Suppl 1 |
p. 722-742
|
article
|
| 43 |
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
|
Mat Nor, Mohd Nasir
|
|
|
17 |
Suppl 1 |
p. 371-387
|
article
|
| 44 |
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
|
Mat Nor, Mohd Nasir
|
|
|
17 |
Suppl 1 |
p. 371-387
|
article
|
| 45 |
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
|
Mat Nor, Mohd Nasir
|
|
|
17 |
Suppl 1 |
p. 371-387
|
article
|
| 46 |
Current Perspectives on Aerobic Exercise in People with Parkinson’s Disease
|
Schootemeijer, Sabine
|
|
|
17 |
Suppl 1 |
p. 1418-1433
|
article
|
| 47 |
Current Perspectives on Aerobic Exercise in People with Parkinson's Disease
|
Schootemeijer, Sabine
|
|
|
17 |
Suppl 1 |
p. 1418-1433
|
article
|
| 48 |
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats
|
Sharma, Puneet K.
|
|
|
17 |
Suppl 1 |
p. 1120-1141
|
article
|
| 49 |
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats
|
Sharma, Puneet K.
|
|
|
17 |
Suppl 1 |
p. 1120-1141
|
article
|
| 50 |
FG-4592 Improves Depressive-Like Behaviors through HIF-1-Mediated Neurogenesis and Synapse Plasticity in Rats
|
Li, Gaifen
|
|
|
17 |
Suppl 1 |
p. 664-675
|
article
|
| 51 |
FG-4592 Improves Depressive-Like Behaviors through HIF-1-Mediated Neurogenesis and Synapse Plasticity in Rats
|
Li, Gaifen
|
|
|
17 |
Suppl 1 |
p. 664-675
|
article
|
| 52 |
From Genetic Testing to Precision Medicine in Epilepsy
|
Striano, Pasquale
|
|
|
17 |
Suppl 1 |
p. 609-615
|
article
|
| 53 |
From Genetic Testing to Precision Medicine in Epilepsy
|
Striano, Pasquale
|
|
|
17 |
Suppl 1 |
p. 609-615
|
article
|
| 54 |
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease
|
Tian, Ye
|
|
|
17 |
Suppl 1 |
p. 1796-1812
|
article
|
| 55 |
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease
|
Tian, Ye
|
|
|
17 |
Suppl 1 |
p. 1796-1812
|
article
|
| 56 |
Generalization of Conditioned Contextual Anxiety and the Modulatory Effects of Anxiety Sensitivity
|
Andreatta, Marta
|
|
|
17 |
Suppl 1 |
p. 1239-1252
|
article
|
| 57 |
Generalization of Conditioned Contextual Anxiety and the Modulatory Effects of Anxiety Sensitivity
|
Andreatta, Marta
|
|
|
17 |
Suppl 1 |
p. 1239-1252
|
article
|
| 58 |
HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window
|
Zhao, Junli
|
|
|
17 |
Suppl 1 |
p. 710-721
|
article
|
| 59 |
HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window
|
Zhao, Junli
|
|
|
17 |
Suppl 1 |
p. 710-721
|
article
|
| 60 |
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential
|
Artusi, Carlo Alberto
|
|
|
17 |
Suppl 1 |
p. 1736-1746
|
article
|
| 61 |
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential
|
Artusi, Carlo Alberto
|
|
|
17 |
Suppl 1 |
p. 1736-1746
|
article
|
| 62 |
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study
|
Prosperini, Luca
|
|
|
17 |
Suppl 1 |
p. 994-1004
|
article
|
| 63 |
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study
|
Prosperini, Luca
|
|
|
17 |
Suppl 1 |
p. 994-1004
|
article
|
| 64 |
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
|
Zhou, Lin
|
|
|
17 |
Suppl 1 |
p. 340-355
|
article
|
| 65 |
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
|
Zhou, Lin
|
|
|
17 |
Suppl 1 |
p. 340-355
|
article
|
| 66 |
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
|
Zhou, Lin
|
|
|
17 |
Suppl 1 |
p. 340-355
|
article
|
| 67 |
Management of psychiatric disorders in Parkinson’s disease
|
Weintraub, Daniel
|
|
|
17 |
Suppl 1 |
p. 1511-1524
|
article
|
| 68 |
Management of psychiatric disorders in Parkinson's disease
|
Weintraub, Daniel
|
|
|
17 |
Suppl 1 |
p. 1511-1524
|
article
|
| 69 |
Management of Tardive Syndrome: Medications and Surgical Treatments
|
Factor, Stewart A.
|
|
|
17 |
Suppl 1 |
p. 1694-1712
|
article
|
| 70 |
Management of Tardive Syndrome: Medications and Surgical Treatments
|
Factor, Stewart A.
|
|
|
17 |
Suppl 1 |
p. 1694-1712
|
article
|
| 71 |
Managing Essential Tremor
|
Hopfner, Franziska
|
|
|
17 |
Suppl 1 |
p. 1603-1621
|
article
|
| 72 |
Managing Essential Tremor
|
Hopfner, Franziska
|
|
|
17 |
Suppl 1 |
p. 1603-1621
|
article
|
| 73 |
Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models
|
Wu, Bin
|
|
|
17 |
Suppl 1 |
p. 1878-1896
|
article
|
| 74 |
Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models
|
Wu, Bin
|
|
|
17 |
Suppl 1 |
p. 1878-1896
|
article
|
| 75 |
N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug
|
Kamiński, Krzysztof
|
|
|
17 |
Suppl 1 |
p. 309-328
|
article
|
| 76 |
N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug
|
Kamiński, Krzysztof
|
|
|
17 |
Suppl 1 |
p. 309-328
|
article
|
| 77 |
Neurocritical Care: Bench to Bedside (Eds. Claude Hemphill, Michael James) Integrating and Using Big Data in Neurocritical Care
|
Foreman, Brandon
|
|
|
17 |
Suppl 1 |
p. 593-605
|
article
|
| 78 |
Neurocritical Care: Bench to Bedside (Eds. Claude Hemphill, Michael James) Integrating and Using Big Data in Neurocritical Care
|
Foreman, Brandon
|
|
|
17 |
Suppl 1 |
p. 593-605
|
article
|
| 79 |
Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain
|
Li, Xu-Hui
|
|
|
17 |
Suppl 1 |
p. 861-873
|
article
|
| 80 |
Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain
|
Li, Xu-Hui
|
|
|
17 |
Suppl 1 |
p. 861-874
|
article
|
| 81 |
Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice
|
Olson, Katherine E.
|
|
|
17 |
Suppl 1 |
p. 1861-1877
|
article
|
| 82 |
Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice
|
Olson, Katherine E.
|
|
|
17 |
Suppl 1 |
p. 1861-1877
|
article
|
| 83 |
One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial
|
Dindo, Lilian N.
|
|
|
17 |
Suppl 1 |
p. 743-753
|
article
|
| 84 |
One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial
|
Dindo, Lilian N.
|
|
|
17 |
Suppl 1 |
p. 743-753
|
article
|
| 85 |
Palliative Care for Parkinson’s Spectrum Disorders: an Emerging Approach
|
Katz, Maya
|
|
|
17 |
Suppl 1 |
p. 1456-1463
|
article
|
| 86 |
Palliative Care for Parkinson's Spectrum Disorders: an Emerging Approach
|
Katz, Maya
|
|
|
17 |
Suppl 1 |
p. 1456-1463
|
article
|
| 87 |
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease
|
Griñán-Ferré, Christian
|
|
|
17 |
Suppl 1 |
p. 1825-1835
|
article
|
| 88 |
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
|
Griñán-Ferré, Christian
|
|
|
17 |
Suppl 1 |
p. 1825-1835
|
article
|
| 89 |
Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice
|
Kim, Namkwon
|
|
|
17 |
Suppl 1 |
p. 189-199
|
article
|
| 90 |
Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice
|
Kim, Namkwon
|
|
|
17 |
Suppl 1 |
p. 189-199
|
article
|
| 91 |
Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice
|
Kim, Namkwon
|
|
|
17 |
Suppl 1 |
p. 189-199
|
article
|
| 92 |
Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood–Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats
|
Fang, Yuanjian
|
|
|
17 |
Suppl 1 |
p. 1954-1972
|
article
|
| 93 |
Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood–Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats
|
Fang, Yuanjian
|
|
|
17 |
Suppl 1 |
p. 1954-1972
|
article
|
| 94 |
Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model
|
Meloni, Bruno P.
|
|
|
17 |
Suppl 1 |
p. 627-634
|
article
|
| 95 |
Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model
|
Meloni, Bruno P.
|
|
|
17 |
Suppl 1 |
p. 627-634
|
article
|
| 96 |
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
|
Branger, Pierre
|
|
|
17 |
Suppl 1 |
p. 989-993
|
article
|
| 97 |
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
|
Branger, Pierre
|
|
|
17 |
Suppl 1 |
p. 989-993
|
article
|
| 98 |
RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
|
Abdallah, Mahmoud S.
|
|
|
17 |
Suppl 1 |
p. 1897-1906
|
article
|
| 99 |
RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
|
Abdallah, Mahmoud S.
|
|
|
17 |
Suppl 1 |
p. 1897-1906
|
article
|
| 100 |
Retraction Note to: Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters
|
Shah, Syed Zahid Ali
|
|
|
17 |
Suppl 1 |
p. 2091
|
article
|
| 101 |
Retraction Note to: Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters
|
Shah, Syed Zahid Ali
|
|
|
17 |
Suppl 1 |
p. 2091
|
article
|
| 102 |
Septic-Associated Encephalopathy: a Comprehensive Review
|
Mazeraud, Aurélien
|
|
|
17 |
Suppl 1 |
p. 392-403
|
article
|
| 103 |
Septic-Associated Encephalopathy: a Comprehensive Review
|
Mazeraud, Aurélien
|
|
|
17 |
Suppl 1 |
p. 392-403
|
article
|
| 104 |
Subcutaneous administration of β-hydroxybutyrate improves learning and memory of sepsis surviving mice
|
Wang, Xueqin
|
|
|
17 |
Suppl 1 |
p. 616-626
|
article
|
| 105 |
Subcutaneous administration of β-hydroxybutyrate improves learning and memory of sepsis surviving mice
|
Wang, Xueqin
|
|
|
17 |
Suppl 1 |
p. 616-626
|
article
|
| 106 |
Tanshinone IIA Ameliorates CNS Autoimmunity by Promoting the Differentiation of Regulatory T Cells
|
Gong, Ye
|
|
|
17 |
Suppl 1 |
p. 690-703
|
article
|
| 107 |
Tanshinone IIA Ameliorates CNS Autoimmunity by Promoting the Differentiation of Regulatory T Cells
|
Gong, Ye
|
|
|
17 |
Suppl 1 |
p. 690-703
|
article
|
| 108 |
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
|
Marschallinger, Julia
|
|
|
17 |
Suppl 1 |
p. 1061-1074
|
article
|
| 109 |
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
|
Marschallinger, Julia
|
|
|
17 |
Suppl 1 |
p. 1061-1074
|
article
|
| 110 |
Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis
|
Mòdol-Caballero, Guillem
|
|
|
17 |
Suppl 1 |
p. 1048-1060
|
article
|
| 111 |
Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis
|
Mòdol-Caballero, Guillem
|
|
|
17 |
Suppl 1 |
p. 1048-1060
|
article
|
| 112 |
Therapeutic Update on Huntington’s Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies
|
Dash, Deepa
|
|
|
17 |
Suppl 1 |
p. 1645-1659
|
article
|
| 113 |
Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies
|
Dash, Deepa
|
|
|
17 |
Suppl 1 |
p. 1645-1659
|
article
|
| 114 |
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity
|
Micheli, Laura
|
|
|
17 |
Suppl 1 |
p. 1005-1015
|
article
|
| 115 |
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity
|
Micheli, Laura
|
|
|
17 |
Suppl 1 |
p. 1005-1015
|
article
|
| 116 |
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials
|
Chrzanowski, Stephen M.
|
|
|
17 |
Suppl 1 |
p. 142-152
|
article
|
| 117 |
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials
|
Chrzanowski, Stephen M.
|
|
|
17 |
Suppl 1 |
p. 142-152
|
article
|
| 118 |
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials
|
Chrzanowski, Stephen M.
|
|
|
17 |
Suppl 1 |
p. 142-152
|
article
|
| 119 |
Translational Genomics in Neurocritical Care: a Review
|
Myserlis, Pavlos
|
|
|
17 |
Suppl 1 |
p. 563-580
|
article
|
| 120 |
Translational Genomics in Neurocritical Care: a Review
|
Myserlis, Pavlos
|
|
|
17 |
Suppl 1 |
p. 563-580
|
article
|
| 121 |
TSPO PET Identifies Different Anti-inflammatory Minocycline Treatment Response in Two Rodent Models of Epileptogenesis
|
Wolf, Bettina J.
|
|
|
17 |
Suppl 1 |
p. 1228-1238
|
article
|
| 122 |
TSPO PET Identifies Different Anti-inflammatory Minocycline Treatment Response in Two Rodent Models of Epileptogenesis
|
Wolf, Bettina J.
|
|
|
17 |
Suppl 1 |
p. 1228-1238
|
article
|
| 123 |
Vildagliptin Attenuates Huntington’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
|
Sayed, Noha H.
|
|
|
17 |
Suppl 1 |
p. 252-268
|
article
|
| 124 |
Vildagliptin Attenuates Huntington’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
|
Sayed, Noha H.
|
|
|
17 |
Suppl 1 |
p. 252-268
|
article
|
| 125 |
Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
|
Sayed, Noha H.
|
|
|
17 |
Suppl 1 |
p. 252-268
|
article
|
Journal description